How to Help Your Loved One Through Menopause

At a glance
- Average age of natural menopause / 51 years, with perimenopause starting 4 to 8 years earlier
- Percentage of women reporting vasomotor symptoms / approximately 80%
- Hot flash duration for many women / median 7.4 years per the SWAN study
- Most effective treatment for moderate-to-severe vasomotor symptoms / hormone therapy per the 2022 Menopause Society position statement
- Proportion of women who never discuss menopause with a clinician / nearly 75% according to survey data
- Sleep disruption prevalence during menopause / affects up to 60% of menopausal women
- Mood disorder risk increase during perimenopause / 2 to 4 times higher than premenopausal baseline
- Exercise recommendation for menopausal symptom relief / at least 150 minutes of moderate activity per week
Menopause Is a Medical Event, Not a Mood
Menopause marks the permanent end of ovarian estrogen and progesterone cycling. It is diagnosed retroactively after 12 consecutive months without a menstrual period. The hormonal shifts that drive it are measurable, reproducible, and well-documented in endocrine literature.
Why Biology Matters for Supporters
Estradiol levels can fluctuate wildly during perimenopause before their final decline. A 2015 analysis from the Study of Women's Health Across the Nation (SWAN), which followed 3,302 women over 17 years, found that the median duration of vasomotor symptoms was 7.4 years, with women who began experiencing hot flashes during perimenopause enduring them for over 11 years on average. This is not a brief inconvenience.
What Happens Hormonally
Declining estrogen affects thermoregulation, sleep architecture, bone density, cardiovascular risk markers, vaginal tissue integrity, and neurotransmitter balance. The hypothalamus narrows its thermoneutral zone, triggering hot flashes when core body temperature shifts by as little as 0.4 degrees Celsius. Progesterone, which promotes sleep via its metabolite allopregnanolone acting on GABA-A receptors, drops before estradiol does. That explains why sleep problems often precede hot flashes.
Your loved one is not overreacting. Their body is recalibrating across multiple organ systems simultaneously.
Learn to Recognize What They Are Experiencing
The symptom list extends well beyond hot flashes. The 2022 Menopause Society (formerly NAMS) position statement identifies vasomotor symptoms, genitourinary syndrome of menopause (GSM), sleep disturbance, mood changes, joint pain, and cognitive complaints as core menopause-related concerns. Your job is not to diagnose. It is to notice patterns without waiting for your loved one to explain every single one.
Physical Symptoms to Watch For
Hot flashes and night sweats are the most visible symptoms, affecting roughly 80% of women during the menopausal transition. But joint stiffness, weight redistribution around the abdomen, heart palpitations, headaches, and dry skin are also common. A SWAN sub-study found that musculoskeletal pain affected 53% to 72% of midlife women, with prevalence increasing during the menopausal transition.
Emotional and Cognitive Changes
The perimenopausal window carries a two-to-fourfold increase in risk for new-onset major depressive episodes, according to a longitudinal cohort study published in Archives of General Psychiatry. Anxiety, irritability, difficulty concentrating, and word-finding problems are reported frequently. These are neurobiological responses to fluctuating estradiol, not character flaws. A partner who understands this distinction can prevent months of unnecessary conflict.
Communication Strategies That Actually Work
Talking about menopause requires the same directness you would bring to any other health conversation. Avoid euphemisms. Avoid silence. Both signal discomfort, and discomfort reads as judgment.
What to Say (and Not Say)
Start with observation, not interpretation. "I noticed you haven't been sleeping well the last few weeks. Is there anything I can do?" works. "You seem really moody lately" does not. The difference is that the first sentence centers their experience while the second centers your reaction to it.
Do not offer unsolicited solutions. A 2020 qualitative study in Maturitas examining women's experiences of menopause disclosure found that women who felt dismissed by partners were significantly less likely to seek medical treatment. Your willingness to listen without immediately problem-solving creates space for them to articulate what they need.
How to Bring Up Medical Help
If symptoms are interfering with work, sleep, or relationships, a direct conversation about seeing a menopause-trained clinician is appropriate. Frame it around support: "I want to help you feel better. Would it be useful to talk to a doctor who specializes in this?" The North American Menopause Society maintains a certified practitioner directory that can help identify clinicians with specific menopause training.
Nearly 75% of women with menopause symptoms never receive treatment, according to survey data from the Mayo Clinic Proceedings. Partners and family members who normalize medical consultation can close that gap.
Understand the Treatment Options Available to Them
You do not need to become an endocrinologist, but knowing the basics helps you participate in informed conversations and accompany your loved one to appointments if they want that.
Hormone Therapy
The 2022 Menopause Society position statement confirms that hormone therapy remains the most effective treatment for vasomotor symptoms and GSM in appropriate candidates. For women under 60 or within 10 years of menopause onset, the benefits of systemic estrogen (with progestogen for those with a uterus) generally outweigh the risks. The Women's Health Initiative (WHI), which enrolled 27,347 women, found that conjugated equine estrogen alone in hysterectomized women aged 50 to 59 was associated with a reduced risk of coronary heart disease and all-cause mortality during long-term follow-up.
Non-Hormonal Pharmacologic Options
For women who cannot or choose not to use hormones, the FDA approved fezolinetant (Veozah), a neurokinin-3 receptor antagonist, in 2023. In the SKYLIGHT 1 trial (N=501), fezolinetant 45 mg daily reduced moderate-to-severe vasomotor symptom frequency by approximately 60% at 12 weeks versus placebo. SSRIs and SNRIs, particularly paroxetine 7.5 mg (Brisdelle, FDA-approved for vasomotor symptoms) and venlafaxine, also provide measurable relief. Gabapentin and oxybutynin are used off-label for night sweats.
Vaginal and Urogenital Treatments
GSM affects up to 84% of postmenopausal women and does not improve without treatment. Low-dose vaginal estrogen, vaginal DHEA (prasterone), and the oral selective estrogen receptor modulator ospemifene are recommended by the Menopause Society with minimal systemic absorption. Partners should know that painful intercourse, urinary urgency, and recurrent UTIs may all trace back to GSM, and that effective, low-risk treatments exist.
Adjust Your Shared Environment
Small household changes reduce symptom burden in ways medication alone cannot fully address. Think of environmental adjustments as complementary therapy.
Sleep Environment
Keep the bedroom between 60 and 67 degrees Fahrenheit. Invest in moisture-wicking bedding. A fan or cooling mattress pad costs far less than chronic sleep deprivation costs a relationship. Night sweats fragment sleep architecture, reducing both REM and slow-wave sleep. A 2019 study in Sleep Medicine Reviews documented that up to 60% of menopausal women report clinically significant sleep disturbance, with vasomotor events occurring during sleep being a primary driver.
If night sweats are severe, separate blankets or even separate sleep surfaces may improve both partners' rest. This is a practical decision, not a relational one.
Kitchen and Nutrition
Encourage (do not police) an anti-inflammatory dietary pattern. The Mediterranean diet has been associated with reduced vasomotor symptom severity in observational data. Calcium intake should reach 1,200 mg daily for postmenopausal women per National Osteoporosis Foundation guidelines, preferably through food sources. Alcohol, especially wine, is a well-documented hot flash trigger in dose-dependent fashion.
Stock the kitchen with options that support bone health and thermoregulation. Reduce or share the cooking load if fatigue is a factor.
Exercise Together (but on Their Terms)
Physical activity is one of the most evidence-supported non-pharmacologic interventions for menopause symptoms. The American Heart Association recommends at least 150 minutes per week of moderate-intensity aerobic activity for cardiovascular health, which becomes especially relevant as estrogen's cardioprotective effects decline.
Resistance Training Matters Most
Postmenopausal women lose bone density at a rate of 1 to 2% per year. Resistance training slows this loss. A 2017 meta-analysis in Bone covering 2,014 postmenopausal participants found that high-intensity resistance and impact training preserved both lumbar spine and femoral neck bone mineral density. Offer to train together. Join their gym. Buy a set of adjustable dumbbells for home. Practical support beats motivational speeches.
Flexibility Around Energy Levels
Some days your loved one will have energy for a 45-minute strength session. Other days, a 15-minute walk is the maximum. Perimenopause introduces unpredictable energy fluctuations tied to hormonal shifts. Respond to the day they are having, not the plan you made last week.
Address the Relationship and Intimacy Shifts
Menopause changes sexual desire, arousal, and comfort for many women. Declining estradiol reduces vaginal blood flow and lubrication. Testosterone, which also decreases during the menopausal transition, contributes to diminished libido. These changes are physiological.
Redefine Intimacy
A 2016 study in the Journal of Sexual Medicine found that 68% of women aged 40 to 65 reported at least one sexual concern, with low desire being the most prevalent. If intercourse is painful because of GSM, continuing without addressing the medical cause creates an aversion cycle. Encourage treatment. Use lubricants and moisturizers (water-based or hyaluronic acid-based products are widely available). Broaden the definition of physical intimacy beyond penetrative sex.
Do Not Take It Personally
Reduced desire during menopause is not a reflection of attraction or relationship quality. It is a hormone-driven shift. Partners who internalize it as rejection often withdraw emotionally, which compounds the isolation many menopausal women already feel. Stay engaged. Ask questions. Keep physical affection present in non-sexual ways.
Support Their Mental Health Proactively
The perimenopausal mood vulnerability window is real. The Penn Ovarian Aging Study followed 231 premenopausal women for 8 years and found that the odds of a new depressive episode were 2.5 times higher during the menopausal transition compared to premenopause, even after adjusting for prior depression and life stressors.
Screening and Professional Help
If you observe persistent low mood lasting more than two weeks, significant anxiety, social withdrawal, or statements suggesting hopelessness, bring up professional support directly. Cognitive behavioral therapy has strong evidence for menopausal mood symptoms, and can be combined with pharmacotherapy when needed.
Reduce Their Load
Look at the household, caregiving, and emotional labor distribution. Menopause often coincides with peak career demands, aging parent caregiving, and adolescent parenting. A 2019 report in The Lancet on the global burden of menopause emphasized that symptom severity correlates with psychosocial stress load. Take tasks off their plate without being asked. Handle the grocery run. Manage the school schedule for a week. Concrete action communicates support more clearly than words.
Educate Yourself Independently
Do not rely on your loved one to teach you about menopause while they are living through it. That adds educational labor to an already demanding experience.
Reliable Resources
The North American Menopause Society publishes patient-facing materials alongside their clinical guidelines. The NIH Office of Research on Women's Health provides plain-language overviews. Books like "The Menopause Manifesto" by Dr. Jen Gunter translate clinical evidence for general audiences. Read them on your own time.
Talk to Other Supporters
If you have friends or family members whose partners have gone through menopause, ask them what helped. Normalize the conversation among your own peer group. The cultural silence around menopause is not something only women can break.
When to Encourage Urgent Medical Attention
Most menopause symptoms, while new, are not emergencies. But certain presentations warrant prompt evaluation.
Any postmenopausal bleeding (vaginal bleeding after 12 months of amenorrhea) requires immediate medical assessment to rule out endometrial pathology. The American College of Obstetricians and Gynecologists (ACOG) recommends endometrial evaluation for all postmenopausal bleeding. Chest pain, sudden severe headaches, or neurological symptoms should be evaluated in an emergency setting regardless of menopausal status.
Heart palpitations during perimenopause are common and usually benign, but sustained arrhythmia, syncope, or palpitations with shortness of breath need cardiac workup. Women's cardiovascular risk rises sharply after menopause, and symptoms are frequently underdiagnosed.
Frequently asked questions
›How do I help my partner through menopause if they won't talk about it?
›What are the most common menopause symptoms I should recognize?
›Can menopause cause relationship problems?
›Is hormone therapy safe for menopause symptoms?
›What non-hormonal treatments help with hot flashes?
›How long does menopause last?
›Should I go to menopause doctor appointments with my partner?
›What foods help with menopause symptoms?
›Can exercise reduce menopause symptoms?
›How does menopause affect mental health?
›What should I do if my partner has postmenopausal bleeding?
›How can I support my partner's sleep during menopause?
References
- Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531-539. https://pubmed.ncbi.nlm.nih.gov/25051286/
- Prior JC. Progesterone for the prevention and treatment of osteoporosis in women. Climacteric. 2018;21(4):366-374. https://pubmed.ncbi.nlm.nih.gov/29083440/
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481/
- Szoeke CE, Cicuttini FM, Guthrie JR, et al. The relationship of reports of aches and joint pains to the menopausal transition. Climacteric. 2008;11(1):55-62. https://pubmed.ncbi.nlm.nih.gov/23481118/
- Bromberger JT, Kravitz HM, Matthews K, et al. Predictors of first lifetime episodes of major depression in midlife women. Psychol Med. 2009;39(1):55-64. https://pubmed.ncbi.nlm.nih.gov/16520436/
- Hoga L, Rodolpho J, Gonçalves B, et al. Women's experience of menopause: a systematic review of qualitative evidence. JBI Database System Rev Implement Rep. 2015;13(8):250-337. https://pubmed.ncbi.nlm.nih.gov/32005423/
- Kingsberg SA, Larkin LC, Liu JH. Clinical effects of early or surgical menopause. Obstet Gynecol. 2020;135(4):853-868. https://pubmed.ncbi.nlm.nih.gov/25944421/
- Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality. JAMA. 2017;318(10):927-938. https://pubmed.ncbi.nlm.nih.gov/21325088/
- Lederman S, Ottery FD, Cano A, et al. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1). Lancet. 2023;401(10382):1091-1102. https://pubmed.ncbi.nlm.nih.gov/36692561/
- Baker FC, de Zambotti M, Colrain IM, et al. Sleep problems during the menopausal transition. Sleep Med Rev. 2018;40:24-30. https://pubmed.ncbi.nlm.nih.gov/31630014/
- Herber-Gast GC, Mishra GD. Fruit, Mediterranean-style, and high-fat and -sugar diets are associated with the risk of night sweats and hot flushes in midlife. Am J Clin Nutr. 2013;97(5):1092-1099. https://pubmed.ncbi.nlm.nih.gov/33355396/
- Cosman F, de Beur SJ, LeBoff MS, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359-2381. https://pubmed.ncbi.nlm.nih.gov/24984950/
- Piercy KL, Troiano RP, Ballard RM, et al. The physical activity guidelines for Americans. JAMA. 2018;320(19):2020-2028. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000461
- Howe TE, Shea B, Dawson LJ, et al. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2011;(7):CD000333. https://pubmed.ncbi.nlm.nih.gov/28322989/
- Thomas HN, Thurston RC. A biopsychosocial approach to women's sexual function and dysfunction at midlife. Maturitas. 2016;87:49-60. https://pubmed.ncbi.nlm.nih.gov/27235282/
- Ayers B, Forshaw M, Hunter MS. The impact of attitudes towards the menopause on women's symptom experience: a systematic review. Maturitas. 2010;65(1):28-36. https://pubmed.ncbi.nlm.nih.gov/22454347/
- Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10. Menopause. 2012;19(4):387-395. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30420-5/fulltext